Advertisement

Topics

Roche trumpets APHINITY data, but did it hit the mark?

07:30 EDT 6 Jun 2017 | PMLIVE

Results raise questions about benefit of combining Herceptin with Perjeta

Original Article: Roche trumpets APHINITY data, but did it hit the mark?

NEXT ARTICLE

More From BioPortfolio on "Roche trumpets APHINITY data, but did it hit the mark?"

Quick Search
Advertisement